News
In 2022, the SWEETSTONE 21 study protocol was published, aiming to evaluate the impact of empagliflozin on urinary SS in a randomized, double-blind, placebo-controlled, cross-over study. The inclusion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback